Relay Therapeutics, Inc. Cash Flow Statement

Cash Flow Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -75.31M-52.41M-363.87M-290.49M-341.95M-337.72M
Depreciation and Depletion 2.85M3.55M3.92M4.13M5.27M5.46M
Share-based Compensation 4.46M31.96M48.45M56.14M86.03M94.14M
Gains from Sales and Divestitures 0.58M0.08M0.40M0.88M2.13M
Gains from Investment Securities 24.94M7.70M6.91M46.63M12.39M0.10M
Non-cash Items 196.63M2.97M4.42M6.65M7.86M
Cash from Operations -66.13M-102.49M-74.41M-229.49M-300.32M-249.11M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 2.50M0.42M-2.05M-1.18M10.76M12.31M
Depreciation & Amortization (CF) 2.85M3.55M3.92M4.13M5.27M5.46M
Change in Working Capital
Change in Receivables 75.00M-74.68M-0.10M-0.31M
Change in Account Payables 3.00M-0.41M0.93M1.99M-2.39M
Change in Accured Expenses 2.20M2.01M21.00M11.29M-24.95M10.27M
Investing Activities
Capital Expenditures 8.00M1.93M3.47M9.06M4.13M2.02M
Sales of Property, Plant and Equipment 0.02M
Acquisitions 25.30M
Change in Acquisitions & Divestments 242.47M350.06M529.92M355.74M647.30M611.56M
Cash from Investing Activities -319.02M81.67M-479.51M-188.75M257.63M-41.08M
Financing Activities
Change in Capital Stock
Shares Issued 0.61M425.29M1.14M1.69M30.30M17.90M
Preferred Shares Issued 4.99M
Misc.
Cash from Financing Activities 5.61M426.51M388.09M289.91M34.75M270.15M
Change in Cash -379.55M405.69M-165.83M-128.32M-7.93M-20.04M
Free Cash Flow -74.14M-104.42M-77.88M-238.55M-304.44M-251.12M
Net Cash Flow -379.55M405.69M-165.83M-128.32M-7.93M-20.04M